Summary
In a controlled clinical trial the efficacy of a certain drug can be tested. The question is whether this drug is also effective within an individual patient. For the quantitative recording of ventricular arrhythmias a long term ECG monitoring is used. The evaluation of the ECG findings with respect to an effect of an anti-arrhythmic drug is a problem especially due to the high spontaneous variation in arrhythmic freqencies.
Previously a 50 to 70 per cent reduction of ventricular premature depolarization (=VPD) over 24 hours has been used as an index of efficacy.
In the last years some authors tried to establish objective criteria for assessing such an index based upon biostatistical methods. The different methods lead to different results in the minimal percantage reduction in VPD frequency required to demonstrate an effect due to the intervention rather than spontaneous variation at a certain level of confidence. The range for the reduction ist from 65 to 100 per cent for a period of 24 hours or longer. This is not feasible in reality, for one has to select an appropriate drug under several possible drugs. Therefore we developed a method which allows, within a period of 5 hours after injection, to exclude drugs with no effect. The reduction must be 50 to 60 per cent. The comparison with the existing methods confirms our findings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bigger, J. T., Rolnitzky, L. U. (1985): The evaluation of antiarrhythmic drug efficacy. In: Reiser, J. H., Horowitz, L. N. eds: Mechanisms and Treatment of Cardiac Arrhythmias, p.117-135
Gaughan, C. E., Lown, B., Lanigan, J., Voukydis, P., Beser, H. (1976): Acute oral drug testing for determining antiarrhythmic drug efficacy. 1. Quinidine Amer J Cardiol 38: 677–684
Goedel-Meinen, L., Schmidt, G., Jahns, G. (1985): Antiarrhythmische Therapie chronischer ventrikulärer Herzrhythmusstörungen In: G. Schmidt, L.Goedel-Meinen, H. Blömer (Hsrg.): Bedeutung, Diagnostik und Therapie ventrikulärer Herzrhythmusstörungen Tempo Medical, 71-84
Graboys, T. B., Lown, B., Podrid, P. J., De-Silva, R. (1982): Long-term survival of patients with malignant ventricular arrhythmia treated uith antiarrhythmic drugs. Am J Cardiol 50: 437–443
Jelinek, M. V., Lohrbaucher, L., Lown, B.(1974): Antiarrhythmic drug therapy for sporadic ventricular ectopic arrhythmias. Circ. 49: 659–666
Morganroth, J., Michelson, E. L., Horowitz, L. N., Josephson, M. E., Pealrman, A. S., Dunkman, U. B. (1978); Limitations of routine long-term monitoring to assess ventricular ectopic frequency. Circulation 58: 408–414
Sami, M., Kraemer, H., Harrison, D. C., Houston, N, Chimasaki, S., DeBusk, R. F. (1980): A neu method for evaluating antiarrhythmic drug efficacy. Circulation 62: 1172–1179
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ulm, K., Schmidt, G. (1985). Statistische Methoden zur Bewertung der Individuellen Wirkung Einer Anti-Arrhythmischen Substanz. In: Jesdinsky, H.J., Trampisch, H.J. (eds) Prognose- und Entscheidungsfindung in der Medizin. Medizinische Informatik und Statistik, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82651-1_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-82651-1_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16068-7
Online ISBN: 978-3-642-82651-1
eBook Packages: Springer Book Archive